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Pluripotent stem cell-derived human primordial germ cell-like cells
(hPGCLCs) provide important opportunities to study primordial
germ cells (PGCs). We robustly produced CD38+ hPGCLCs [∼43% of
FACS-sorted embryoid body (EB) cells] from primed-state induced
pluripotent stem cells (iPSCs) after a 72-hour transient incubation
in the four chemical inhibitors (4i)-naïve reprogramming medium
and showed transcriptional consistency of our hPGCLCs with
hPGCLCs generated in previous studies using various and distinct
protocols. Both CD38+ hPGCLCs and CD38− EB cells significantly
expressed PRDM1 and TFAP2C, although PRDM1 mRNA in CD38−
cells lacked the 3′-UTR harboring miRNA binding sites regulating
mRNA stability. Genes up-regulated in hPGCLCs were enriched for
cell migration genes, and their promoters were enriched for the
binding motifs of TFAP2 (which was identified in promoters of T,
NANOS3, and SOX17) and the RREB-1 cell adhesion regulator. In
EBs, hPGCLCs were identified exclusively in the outermost surface
monolayer as dispersed cells or cell aggregates with strong and
specific expression of POU5F1/OCT4 protein. Time-lapse live cell
imaging revealed activemigration of hPGCLCs onMatrigel. Whereas
all hPGCLCs strongly expressed the CXCR4 chemotaxis receptor, its
ligand CXCL12/SDF1 was not significantly expressed in the whole
EBs. Exposure of hPGCLCs to CXCL12/SDF1 induced cell migration
genes and antiapoptosis genes. Thus, our study shows that tran-
scriptionally consistent hPGCLCs can be readily produced from
hiPSCs after transition of their pluripotency from the primed state
using various methods and that hPGCLCs resemble the early-stage
PGCs randomly migrating in the midline region of human embryos
before initiation of the CXCL12/SDF1-guided chemotaxis.
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Pluripotency is the cellular capability to differentiate intoprimordial germ cells (PGCs) and three embryonic germ
layers (1). Studies using mouse models have revealed that plu-
ripotency in vivo is only a transient state gained by cells of the
inner cell mass (ICM) and epiblast during the early stages of
embryonic development. However, mouse ICM cells and epiblast
cells can be maintained indefinitely without losing their pluri-
potency in cell culture as ES cells (ESCs) and epiblast stem cells,
respectively, and engineered epigenetic reprogramming of differ-
entiated cells can gain pluripotency to generate induced pluripo-
tent stem cells (iPSCs). Whereas human pluripotent stem cells
(hPSCs) maintained in the mTeSR1 medium on Matrigel has a
primed-state pluripotency (1), Gafni et al. (2) showed that it can
be converted into a naïve state when grown in the naïve human
stem cell medium (NHSM). Although transgene-free conversion
of primed hPSCs to naïve state was subsequently achieved under
several different cell culture conditions, features of the achieved
naïve pluripotency varied significantly (1, 3), and long-term
maintenance of pluripotent stem cells (PSCs) in a strongly naïve
state may increase risk of chromosomal anomalies (1, 4).
Although PSCs can produce cells resembling PGCs [primor-
dial germ cell-like cells (PGCLCs)] in cell culture (5–14), direct
conversion of mouse PSCs to PGCLCs is inefficient (6). Hayashi
et al. (6) generated cells resembling early epiblast [epiblast-like
cells (EpiLCs)] from mouse PSCs and showed their strong ability
to produce PGCLCs as cell aggregates in the presence of bone
morphogenetic protein 4 (Bmp4). In the absence of Bmp4, ro-
bust PGCLC production can also be achieved by overexpression
of three transcription factors (TFs)—namely Prdm1, Prdm14,
and Tfap2c (7, 14)—or by a single TF Nanog (8) from exogenous
vectors. The high competency of EpiLCs for PGCLC production
is transient, peaking at day 2 of EpiLC induction but largely lost
at day 3 (6, 10). In a previous study (10), we showed robust and
global demethylation of genomic DNA (gDNA) involving era-
sure of DNA methylation at CpG dinucleotides in the imprinting
control regions.
In the first report of efficient human primordial germ cell-like
cell (hPGCLC) production from PSCs, Irie et al. (15) maintained
human induced pluripotent stem cells (hiPSCs) in an ERK-
independent naïve pluripotency state for at least 2 wk in a
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modified NHSM containing LIF, FGF2, and TGF-β1 and four
chemical inhibitors (4i) of MEK, p38MAPK, GSK3β, and JNK.
Aggregates of hPSCs maintained in the 4i medium robustly
differentiated into hPGCLCs, which strongly express NANOS3,
TNAP, and CD38 (15). Efficiency of hPGCLC production from
the conventional primed pluripotency hiPSCs was very low
(<5%) (15), which was later confirmed by Sasaki et al. (16).
Including Irie et al. (15), at least four laboratories reported ef-
ficient hPGCLC production from PSCs (9, 15–18) but with sig-
nificant variations in the intermediate cell cultures and marker
antigens used for FACS enrichment of hPGCLCs (9, 16, 17)
(Table S1).
In this study, we show that a 72-h exposure of the primed
pluripotency hiPSCs in the 4i medium is sufficient for a robust
production of CD38+ hPGCLCs. In contrast to mouse germ
cell development, induction of PRDM1 or TFAP2C did not seem
to be the primary determinant of hiPSC differentiation to
hPGCLCs, agreeing with observations made by Irie et al. (15).
hiPSC differentiation to hPGCLCs in embryoid bodies (EBs)
was associated with enriched induction of genes involved in cell
migration, and most hPGCLCs were observed at the outermost
surface monolayer of EBs. Live cell imaging revealed actively
migrating hPGCLCs forming cellular protrusions. All hPGCLCs
expressed the CXCR4 chemotaxis receptor, whereas its ligand
CXCL12/SDF1 was not significantly expressed in any cells in
EBs. Exposure of hPGCLCs to CXCL12/SDF1 induced genes
involved in cell migration or antiapoptosis. These results suggest
that hPGCLCs in EBs resemble early-stage PGCs randomly
migrating in the midline region of human embryos before initi-
ation of their directional migration (i.e., chemotaxis) toward
genital ridges under the CXCR4-CXCL12 signaling.
Results
Production of CD38+ hPGCLCs from Short-Term 4i Reprogrammed
hiPSCs. Since previous studies showed robust production of
hPGCLCs via various precursor cell cultures (Table S1), we
speculated that the primed pluripotency state may specifically
prevent hPSCs from germline differentiation, while various de-
grees of deviation from it might be more permissive. To examine
this possibility, we exposed primed pluripotency hiPSCs (clone
A4; 46 + XY diploid) to the 4i medium for total 72 h (48-h
exposure as monolayer cultures followed by 24-h exposure as
EBs) and attempted to produce hPGCLCs using the protocol
described by Irie et al. (15) (Fig. 1A). Colonies of A4 iPSCs
grown in the mTeSR1 medium on feeder cells showed typical
morphology of primed pluripotency hPSCs (Fig. 1B, Left),
whereas colonies grown for 48 h in the 4i medium already
showed a densely packed, sharp-edged appearance (Fig. 1B,
Center), which agrees with the reported characteristics of naïve
hPSCs (2). After 72 h of growth in the 4i medium, expression of
DNMT3A and DNMT3B in A4 iPSCs dramatically decreased,
whereas expression of TET1 or DNMT1 was unchanged or only
modestly suppressed, respectively (Fig. 1C, Left). Strong sup-
pression of DNMT3B expression was obvious after only 24-h
Fig. 1. Production of hPGCLCs from primed pluripotency hiPSCs via 72-h reprogramming toward naïve pluripotency. (A) Diagram of the 11-d schedule of
hPGCLC production from primed pluripotency hiPSCs. (B) Phase contrast images of hiPSCs before and after reprograming toward naïve pluripotency in the 4i
medium and day 5 EBs. (C) mRNA expression of TET1 and DNA methyltransferase genes in the primed and 4i reprogrammed hiPSCs. TaqMan real-time qPCR
measurements (n = 3, mean ± SD). (D) FACS enrichment of CD38+ and CD38− EB cells from days 5 and 8 EBs. FSC, forward scatter. (E) mRNA expression of
germline markers in EBs. TaqMan real-time qPCR measurements (n = 6, mean ± SD).
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incubation in the 4i medium (Fig. 1C, Right). The rapid changes
in expression of the DNMT genes agreed with the characteristics
of hiPSCs grown in the NHSM observed by Gafni et al. (2).
These results support that a 72-h incubation in the 4i medium
was sufficient to significantly deviate the pluripotency of hiPSCs
out of the standard primed state maintained in the mTeSR1
medium. Because both the NHSM and 4i media commonly
contain 1 μM PD0325901 ERK1/2 inhibitor (2, 15), we speculate
that the pluripotency of hiPSCs after a 72-h 4i culture may be
shifted toward the ERK-independent naïve state, although exact
characteristics are unknown.
After a 48-h culture in the 4i medium, we casted hiPSCs into
the AggreWell microwells for rapid formation of EBs using the
spin EB method (19). EBs were formed in the 4i medium within
24 h and then incubated in the PGCLC medium for 5–8 d (Fig.
1B, Right) followed by single-cell dissociation and FACS en-
richment of hPGCLCs as CD38+ cells. FACS contour plots
showed a readily discerned, distinct cell population of CD38+
cells, which corresponded to ∼6 and ∼43% of FACS-sorted cells
after 5 and 8 d of EB culture in the hPGCLC production me-
dium, respectively (Fig. 1D), whereas CD38+ mRNA was
scarcely detected in day 0 EB (Fig. 1C). Real-time qPCR of the
total EB cell lysates revealed that expression of PRDM1, an early
PGC marker gene that encodes a TF required for PGC specifi-
cation (15, 20, 21), was induced by day 2 and reached maximal
strength by day 4 (Fig. 1E). Expression of three other early PGC
marker genes, DPPA3, NANOS3, and CD38, strongly increased
from day 4 to 5, whereas their expression at day 0 was scarcely
detectable (Fig. 1E). Expression of DAZL, a marker of naïve
pluripotency as well as late-stage germline development (22),
was rapidly suppressed in EBs, agreeing with previously pub-
lished studies using other methods of hPGCLC production (16,
20). These results indicate that a 72-h reprogramming of primed
pluripotency hiPSCs in the 4i medium is sufficient for subsequent
robust production of CD38+ hPGCLCs.
Transcriptomal Profiling of CD38+ hPGCLCs Produced via 72-h Pre-EB
4i Reprogramming. To obtain insight into mechanisms of germline
differentiation of hiPSCs, we determined transcriptomes of the
CD38+ hPGCLCs and CD38− cells in day 5 EBs and their pre-
cursors. Unsupervised hierarchical clustering of transcriptomes
(Fig. 2A and Fig. S1 A and B) identified genes significantly
expressed in both CD38+ and CD38− day 5 EB cells but only
weakly expressed in their precursors (cluster 1; 81 genes), genes
expressed predominantly in CD38+ cells over other cell types
(cluster 2; 130 genes), and genes suppressed only in CD38− cells
(cluster 3; 153 genes). Positions of these clusters are indicated on
the right in Fig. 2A, and their enlarged images with full lists of
genes are shown in Fig. S1C. A heat map of marker genes se-
lected from Fig. 2A is also shown as Fig. 2B.
Fig. 2. Transcriptomal profiles of CD38+ hPGCLCs and precursors. (A and B) Unsupervised hierarchical clustering of CD38+ hPGCLCs and their precursors based
on transcriptomes (A) or 24 marker genes (B). Details of the three gene clusters 1–3 indicated in A are shown in Fig. S1 C1–C3, respectively. RNA-seq data were
obtained from three independently performed experiments. Gray color indicates “zero value” data, reflecting the absence of expression. (C) Transcriptomal
PCA. Arrows indicate the path of hiPSC differentiation to CD38+ hPGCLCs and CD38− EB cells. (D) RNA-seq tracks at the 3′-UTR of PRDM1 mRNA. Positions of
exons 6–8, 3′-UTR, and miRNA binding sites are indicated. (E) GO analysis of DEGs between CD38+ hPGCLCs and CD38− EB cells.
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Cluster 1 genes included PRDM1 and naïve pluripotency/ICM
markers TCL1B and TFCP2L1 (16, 20). TFAP2C and another
ICM marker KLF4 (16, 20) were also expressed in both CD38+
and CD38− EB cells relatively strongly, although varying degrees
of weaker expression of TFAP2C were observed with some of the
precursor hPSC cells (Fig. 2 A and B). The weak expression of
TFCP2L1 and KLF4 in both the primed hiPSCs and the short-
term 4i reprogrammed hiPSCs was consistent with the previously
reported characteristics of the primed pluripotency hPSCs and
the ERK-independent naïve pluripotency hiPSCs, respectively
(2, 3, 15), indicating that robust production of CD38+ hPGCLCs
does not require strong expression of these markers of naïve
pluripotency in the pre-EB precursor cultures. Instead, a de-
viation from the primed pluripotency achieved after a 72-h in-
cubation in the 4i medium seems sufficient. However, the ICM
markers TCL1B, TFCP2L1, and KLF4 were strongly expressed
in CD38− cells in day 5 EBs, suggesting a certain degree of
commonality in the gene regulation network between ICM and
EB cells incubated in the hPGCLCs. Cluster 2 genes included
known markers of human primordial germ cells (hPGCs)/
hPGCLCs, such as NANOS3, SOX15, SOX17, and CD38 (15, 22,
23), as well as mesodermal markers T, HOXD1, andWNT3 and a
naïve pluripotency marker TCL1A (16). Cluster 3 genes were
enriched with markers shared by hPSCs and hPGCs/hPGCLCs,
such as ALPL, KIT, NANOG, UTF1, and POU5F1 (15, 16). Many
pluripotency markers (but not hPGC/hPGCLC markers), such as
LIN28A, SALL4, DPPA4, PRDM14, ZIC3, and SOX2, were
strongly expressed in the pluripotent precursor cells (including day
0 EB cells) but only weakly expressed in day 5 EBs. Tran-
scriptomal principal component analysis (PCA) (Fig. 2C) showed
reproducibility of our protocol, although EB cell differentiation to
nongermline lineages seemed somewhat stochastic.
The marker gene expression profile of our CD38+ hPGCLCs
was nearly identical to those of the CD38+/TNAP+ hPGCLCs
produced by Irie et al. (15) from hiPSCs grown in the 4i medium
for at least 2 wk, confirming that the CD38+ cells produced in
this study via a 72-h 4i reprogramming were bona fide hPGCLCs.
Choi et al. (4) recently reported (together with J.O. and T.S.)
that there is a significant risk of chromosomal aneuploidy and
anomalous DNA demethylation in mouse PSCs after prolonged
maintenance (≥20 passages) in the ERK1/2-independent naïve
pluripotency state; our modification of hPGCLC production
protocol using the ERK1/2-inhibiting 4i medium for only a
limited period of time may be beneficial to reduce the risk of
genetic mutations and epimutations, although the effect of
prolonged ERK1/2-repressing culture on hPSCs remains to
be shown.
Not only CD38+ hPGCLCs but also CD38− cells in day 5 EBs
significantly expressed PRDM1 and TFAP2C, which are early-
stage hPGC/hPGCLC markers (15), although expression of
PRDM1 was weaker in CD38− cells than CD38+ cells (Fig. 2 A
and B and Fig. S1 C1 and D). However, the mRNA transcripts
for PRDM1 expressed in CD38− cells lacked most of the
3′-UTR, whereas CD38+ hPGCLCs expressed transcripts with
the full-length 3′-UTR (24, 25) (Fig. 2D and Fig. S2B). Such
3′-UTR length polymorphism seemed to be specific to PRDM1
among genes shown in Fig. 2B (Fig. S2B). The 3′-UTR of PRDM1
mRNA missing in CD38− cells contained binding sites for miRNA
let-7, miR-9, and miR-BHRF1-2 (Fig. 2D and Fig. S2B), which
play significant roles in PRDM1 protein degradation in normal
or malignant human B lymphocytes (26–28). West et al. (21)
reported that in vitro differentiation of mouse ESCs to PGCLCs is
dependent on suppression of let-7 miRNA by Lin28 and that
overexpression of Prdm1 rescued differentiation of lin28-deficient
ESCs to PGCLCs. In our hPGCLC production system, both
LIN28A and LIN28B were significantly expressed in CD38+ and
CD38− cells (Fig. S1D). The possible importance of the 3′-UTR
polymorphism of PRDM1 mRNA and/or let-7 miRNA in hiPSC
differentiation to hPGCLCs remains to be determined.
Gene Ontology (GO) analysis of the differentially expressed
genes (DEGs) between CD38+ and CD38− EB cells [1,445 genes;
false discovery rate (FDR) < 5%; more than fourfold change]
revealed very strong enrichment of genes involved in cell migra-
tion (Fig. 2E, Left) and plasma membrane activities (Fig. 2E,
Right), both of which included formation of cell projections. Most
of the DEGs supporting these enrichments were expressed more
strongly in CD38+ hPGCLCs than CD38− EB cells. These results
suggest that the germline differentiation of EB cells may affect
their ability to change their shape for migration, agreeing with the
reported highly migratory feature of hPGCs (29).
We attempted to determine whether CD38+ hPGCLCs in day
8 EBs reflect a more advanced stage of germline development
than day 5 hPGCLCs (Fig. S3). Transcriptomal PCA (Fig. S3C)
and hierarchical clustering of 3,500 DEGs with the lowest FDRs
(Fig. S3D) revealed a clear distinction between days 5 and 8
CD38+ hPGCLCs. However, GO analysis of these DEGs did not
reveal any meaningful enrichment. Expression of marker genes
for pluripotency or early-stage hPGCs/hPGCLCs was unchanged
between days 5 and 8, except for a slight decrease in LIN28A
expression (Fig. S3E), and expression of late-stage hPGC marker
genes, such as DAZL or DDX4, was not significant. These results
suggest that hPGCLCs at day 8 EB culture did not reflect more
advanced germline differentiation than at day 5. Interestingly,
152 DEGs that were expressed more strongly in day 8 hPGCLCs
than day 5 hPGCLCs (Fig. S3 D, bar F and F) were significantly
enriched with processed pseudogenes derived from ribosomal
protein (RP) genes (eight RPS and three RPL pseudogenes; P <
0.0001 by permutation test) (Fig. S3F, asterisks). Since expres-
sion of processed RP pseudogenes shows strong tissue specificity,
presumably reflecting distinct epigenetic organizations (30), their
differential expression in hPGCLCs might reflect epigenetic
changes between days 5 and 8 EB cultures.
To examine the reproducibility of the transcriptomal profiles
across independent hiPSC clones, we generated two more hiPSC
clones “A5” and “B6” from human neonatal foreskin fibroblasts
using the same method by which clone A4 was generated. All
three hiPSC clones had normal diploid karyotype (46, XY) (Fig.
S4 A and C) and strongly expressed TRA-1–60, TRA-1–81,
POU5F1, and NANOG. These hiPSC clones were subjected to
hPGCLC production [RNA-sequencing (RNA-seq) data nor-
malization (Fig. S4 D and E), hierarchical clustering (Fig. S4 F,
all DEGs and G, selected marker genes), and transcriptomal
PCA (Fig. S4H)], and CD38+ hPGCLCs were isolated from day
7 EBs. Unsupervised clustering (Fig. S4 F and G) and PCA (Fig.
S4H) showed strong reproducibility of transcriptomal profiles for
all three hiPSC clones and all four cell types examined. We then
compared CD38+ hPGCLC and CD38− EB cell transcriptomes
at days 5 (Fig. 2B), 7 (Fig. S4G), and 8 (Fig. S3E) and observed a
decrease in PRDM1 and TFAP2C expression in CD38− cells over
time, whereas the expression of these genes was maintained in
CD38+ hPGCLCs. These results suggest that sustained expres-
sion of PRDM1 and TFAP2C in EB cells may be necessary for
hiPSC differentiation to hPGCLCs.
Transcriptomal Consistency of hPGCLCs Produced Using Various
Protocols and FACS Markers. To obtain insight into biological
consistency of hPGCLCs produced using different protocols
(Table S1), we compared transcriptomes of our hPGCLCs with
those reported by Irie et al. (15) and Sasaki et al. (16) as well as
human fetal gonocytes (23), gestation week 7 hPGCs, gonadal
somatic cells, and the TCam-2 human seminoma cell line (15).
Hierarchical clustering involving 46 selected pluripotency and
germline marker genes clearly separated the subjects into six
clusters corresponding to cell types—namely PSCs, CD38−EB cells,
hPGCLCs, advanced germline cells (AGCs), gonadal somatic cells,
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and TCam-2 (Fig. 3A; color-coded protocols and cell types are
shown in Fig. 3B). The PSC cluster cells strongly expressed pluri-
potency markers (Fig. 3A, rectangle 1). Our CD38− EB cells
strongly expressed ICM/germline markers LEF1, DPPA3, KLF2,
KLF4, TFC2L1, TCL1B, and TFAP2C (Fig. 3A, rectangle 2),
whereas expression of other germline markers, such as CD38,
NANOS3, or SOX17, was low. PRDM1 was significantly expressed
in CD38− EB cells, although less strongly than hPGCLCs. The
hPGCLC cluster cells strongly expressed known hPGC/hPGCLC
markers (Fig. 3A, rectangle 3). The especially strong expression of
five markers—namely T,CD38, PRDM1,NANOS3, and SOX17—in
all hPGCLCs produced by three independent laboratories suggests
their practical usefulness as an hPGCLC signature, whereas ex-
pression of other hPGC/hPGCLC markers, such as TCL1A, KIT,
DND1, SOX15, or GATA4, was either heterogeneous or relatively
low. Expression of late-stage germline markers, including DAZL or
SYCP3, was generally weak in hPGCLCs but strong in week 7 em-
bryonic hPGCs, AGCs, and TCam-2 cells (Fig. 3A, rectangle 4).
PCA with these 46 marker genes also separated the subjects into
five clusters along cell types (Fig. 3C and Fig. S3G). These results
show significant similarity of the CD38+ hPGCLCs produced in this
study with those generated in previous reports.
Hierarchical clustering with 131 genes most strongly expressed
in our CD38+ hPGCLCs (Fig. S1C2) also roughly separated the
subjects along with the cell types (Fig. S5). In this heat map, a set
of 34 genes was strongly expressed in hPGCLCs (Fig. S5 A, blue
bar and B, enlargement), and 9 of them—namely HOXD1,
ALOX5, WNT2, VSTM2B, PLDB1, IRX6, KANK3, TMEM123,
and TMPRSS11E (RP11-387A1.6 is identical to the second exon
of HOXD1)—were specific to hPGCLC. Other genes, including
germline markers NANOS3, SOX17, TCL1A, CD38, T, and
WNT3, were also expressed in 7-wk hPGCs, week 16–16.5 gon-
ocytes, or TCam-2. Several known hPGC markers, such as
PRDM1, TFAP2C, or KIT, were not included in this heat map,
because they were also significantly expressed in CD38− EB cells
and/or pluripotent precursors. Strong expression of NANOS3,
SOX17, TCL1A, T, and CD38 was also observed in hPGCLCs
produced and enriched as KIT+ cells by von Meyenn et al. (9)
(Fig. S6 and Table S1). Expression of UTF1, DND1, or SOX15
was weak in their hPGCLCs (Fig. S6B) as well as hPGCLCs
produced by other laboratories (Fig. 3A, rectangle 3). Significant
induction of NANOS3 and SOX17 was also observed by Sugawa
et al. (17) with their hPGCLCs enriched as KIT+/TRA-1–81+
cells (Table S1). Taken together, these results suggest that
hPGCLCs produced via different pre-EB precursors and/or
FACS enrichment marker antigens have comparable gene
expression characteristics.
Enrichment of TF Binding Motifs in Promoters of DEGs Between CD38+
hPGCLCs and CD38− EB Cells. To obtain insight into the mecha-
nisms of hiPSC differentiation to CD38+ hPGCLCs, we exam-
ined enrichment of TF binding motifs in promoter sequences of
DEGs between CD38+ and CD38− cells in day 5 EBs using the
Transcription Factor (TRANSFAC) database and the F-match
algorithm (31). We identified 13 TF binding motifs that were
significantly enriched in promoters of 537 genes expressed more
strongly in CD38+ hPGCLCs than CD38−EB cells (Fig. 4), whereas
no enriched motifs were found with genes down-regulated in
CD38+ hPGCLCs. Strikingly, 1 of these 13 enriched TF motifs
was the optimal 9-nt TFAP2C binding sequence GCCTGAGGC
Fig. 3. Marker gene expression profiles of human germ cells, hPGCLCs, and precursors across various protocols. (A) Unsupervised hierarchical clustering of
human embryonic and in vitro germline cells generated in four independent laboratories using different protocols. Clustering was performed based on 46marker
genes of pluripotency (blue), PGC (red), and AGCs (green). Color-coded cell types shown at the top of the heat map are indicated in B. Groups of genes expressed
in the (1) pluripotent precursor cells, (2) nongermline EB cells (CD38−), (3) hPGCLCs, and (4) AGCs are shown with yellow rectangles. Gray color indicates zero value
data, reflecting the absence of expression. GS, gonadal somatic cells; TC, TCam-2 human seminoma cells. (B) Color identifications of transcriptomal data. Data from
this study are indicated by red caps in B and circles in C. Data reported by Sasaki et al. (16), Irie et al. (15), and Gkountela et al. (23) are indicated in green, blue, and
orange, respectively. (C) PCA of human embryonic and in vitro germline cells with data shown in A. PC, principal component.
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(32). Although other members of the TFAP2 TFs can also bind to
this sequence, expression of TFAP2C was strongest among them in
CD38+ hPGCLCs and their precursors (Fig. S1E). The list of
44 genes with promoters that harbor predicted TFAP2 binding
consensus motifs (Table S2) included SOX17, NANOS3, and T,
which are robustly expressed in hPGCLC (Figs. 2B and 4B, lo-
cations of TFAP2 binding motifs), suggesting the functional sig-
nificance of TFAP2 for hPGCLC induction. However, our list
showed only a marginal overlap with a previously reported list of
predicted Tfap2c-regulated genes in mouse PGCs (33), sharing as
few as three genes—namely NANOS3, PRUNE2, and GSTM1.
Among other TFs shown in Fig. 4, RREB-1 is also noteworthy,
because it is required for formation of cell protrusions and
lamellipodia as well as the dynamic cell–cell interactions (34).
Localization of CD38+ hPGCLCs at Surface of EBs. Since iPSC dif-
ferentiation to hPGCLCs was associated with enriched expres-
sion of cell migration genes (Fig. 2E), we determined locations of
hPGCLCs in EBs by immunohistochemistry. Because an anti-CD38
antibody suitable for identification of hPGCLCs in formaldehyde-
fixed, paraffin-embedded (FFPE) slides was not available, we
used POU5F1 as an alternative hPGCLC marker antigen (35).
Although POU5F1 was expressed in hPSCs, its expression in day
7 EBs was specific to CD38+ hPGCLCs (Fig. 5A). Unexpectedly,
we observed POU5F1+ hPGCLCs almost exclusively in the
outermost surface monolayer of EB cells (Fig. 5B and Fig. S7B).
The majority of the POU5F1+ cells (>90%) were distributed at
the EB surface without aggregation (Fig. 5B, Left), although
aggregated clusters of POU5F1+ cells were occasionally observed
(Fig. 5B, Right). Significantly biased localization of POU5F1+
hPGCLCs in the outermost surface monolayer of EBs was sta-
tistically confirmed (Fig. 5C). A weak POU5F1 signal, readily
suppressed by low concentrations of a POU5F1 blocking peptide
(Fig. S7A), was also detected predominantly at the subsurface
area of EBs (Fig. S7B). We also attempted to determine quan-
titative aspects of expression of PRDM1 protein by immuno-
fluorescence and immunohistochemistry but were unsuccessful
because of technical difficulties.
Because the DEGs up-regulated in CD38+ hPGCLCs rather
than in CD38− EB cells were enriched for cell migration genes
and because the majority of hPGCLCs at the EB surface were
observed without forming cell aggregates, we speculated that
hPGCLCs may have highly migratory characteristics just as hu-
man embryonic PGCs do (29). To obtain evidence of hPGCLC
migration, we attempted to obtain time-lapse images of CD38+
cells by immunofluorescence staining of live cells. Whole EBs at
day 6 were unsuitable for live fluorescence imaging because of
strong autofluorescence. However, when EBs were inoculated on
Matrigel-coated dishes to spread overnight, cells that emerged
from the EB mass and formed a monolayer were largely free
of autofluorescence. Taking advantage of this observation, we
stained live cells surrounding the immobilized EB masses with a
fluorescence dye-conjugated anti-CD38 antibody and obtained
antibody-dependent fluorescence images matching cell contours
and cellular protrusions (Fig. S7C). Two live fluorescence images
taken at a 60-min time interval showed significant changes in
CD38+ cell shape and location (in Fig. 5D, fluorescence colors
were digitally adjusted to green and orange for images taken be-
fore and after the interval, respectively), agreeing with the highly
migratory nature of human embryonic PGCs (29). Our attempts to
obtain video microscopic tracings of live-stained CD38+ cells were
unsuccessful, apparently because of the apparent sensitivity of
CD38+ cells to changes in the cell culture environment.
Expression of the CXCR4 Chemotactic Cytokine Receptor in CD38+
PGCLCs and Transcriptional Effects of CXCL12. In mouse embryos,
PGCs migrate laterally from the midline regions toward genital
ridges following a gradient of chemoattractant ligand CXCL12/
SDF1 secreted by gonadal somatic cell precursors and its plasma
membrane receptor CXCR4 expressed by PGCs (36). Consistent
with these observations, CXCR4 was strongly expressed in
hPGCLCs and in the TCam-2 seminoma cells, while CXCL12
expression was strong in human embryonic gonadal somatic cells
(Fig. 5E). Neither CD38+ hPGCLCs nor CD38− EB cells
expressed significant amounts of CXCL12 mRNA. FACS con-
tour plots (Fig. 5F) showed that the EB cell population stained
only with either anti-CD38 or anti-CXCR4 antibody completely
disappeared when cells were double-stained with these two
antibodies, while a new CD38+/CXCR4+ double-positive cell
population emerged. These results indicated that all CD38+
hPGCLCs expressed CXCR4 and that all CXCR4-positive
cells in EBs were CD38+ hPGCLCs.
We next attempted to examine the transcriptional effects
of exogenous CXCL12 on gene expression in hPGCLCs (based
on three replicates of RNA-seq). CXCL12-activated CXCR4
signaling in human CD34+ hematopoietic stem cells (37) or
Jurkat T cells (38) requires Rho GTPase-activated kinases 1/2
(ROCK1/2). However, a potent ROCK1/2 inhibitor Y27632 is
included in our hPGCLC medium as well as the media used by
Irie et al. (15), Sasaki et al. (16), and Sugawa et al. (17) but not
that used by von Meyenn et al. (9) (Table S1). When we removed
Y27632 from hPGCLC medium starting at day 5 EB culture,
CD38+ cells isolated at day 7 still strongly expressed NANOS3,
NANOG, and SOX17 as well as CD38 (Fig. 6A), indicating that
Y27632 is dispensable for hPGCLC production on and after day
5. Under this Y27362-free condition, addition of CXCL12 to the
hPGCLC medium on and after day 5 resulted in suppression of
Fig. 4. TF binding motifs enriched in the regulatory sequences of 537 DEGs
expressed more strongly in CD38+ hPGCLCs than in CD38− EB cells. (A) List of
significantly enriched TFs (P < 0.01). The P value was defined by the F-match
algorithm and calculated by the TRANSFAC server. (B) Locations of the
TFAP2 binding motifs in promoters of NANOS3, SOX17, and T/BRACHYURY.
Matches to the core motif (GCCNNNGGC) are shown in red, and matches to
the additional contributing sequences are shown in orange.
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CXCR4 expression (Fig. 6A), consistent with an observation
made with human CD34+ hematopoietic stem cells (37) and
possibly reflecting a negative feedback regulation. Expression of
PTGER3 (encoding prostaglandin E2 receptor isoform 3) and
BCL2 (encoding an antiapoptotic protein) was dramatically in-
duced after exposure to CXCL12, whereas expression of CASP8
(encoding caspase 8, the initiator caspase required for death
receptors-induced apoptosis) was suppressed (Fig. 6A). These
changes in expression of apoptosis-regulating genes suggest that
CXCL12 may reduce CD38+ cell sensitivity to cytokine-induced
apoptosis.
To predict the transcriptomal impact of CXCL12 on CD38+
hPGCLCs, DEGs were identified from the three replicates of
RNA-seq data (1,190 up-regulated and 735 down-regulated in
the presence of CXCL12 during days 5–8 of EB culture in the
PGCLC medium lacking Y27632) and subjected to GO analysis
using the DAVID server. Indeed, GO analysis of CXCL12-
induced DEGs in CD38+ hPGCLCs showed significant enrich-
ment of genes involved in negative regulation of apoptosis as
well as cell migration (Fig. 6B). However, CXCL12-suppressed
DEGs were enriched for genes involved in various aspects of
mitotic nuclear division (Fig. 6C). These results suggest that
CXCR4 activation in hPGCLCs may promote cell migration
coupled with suppression of apoptosis and mitotic nuclear di-
vision. Additional studies will be needed to examine in detail the
biological functions of CXCR4 in hPGCLCs and their relevance
to human embryonic PGCs in vivo.
Discussion
Our study provides evidence that hPGCLCs produced using
different protocols (Table S1), including ours involving only
transient exposure of primed pluripotency hiPSCs to the 4i me-
dium (Fig. 1), share concordant transcriptomal characteristics,
despite a variety of pre-EB precursors and FACS enrichment
Fig. 5. Localization of CD38+ hPGCLCs at the outermost surface layer of EBs. (A) Expression of POU5F1 mRNA transcripts: RNA-seq (n = 3, mean ± SEM).
Statistical significance (t test) is indicated by asterisks. *P < 0.05; **P < 0.01; ***P < 0.001. (B) Localization of POU5F1+ hPGCLCs at the outermost surface layer
of day 8 EBs. hPGCLCs were observed in formaldehyde-fixed, paraffin-embedded EBs by immunohistochemistry. (Left) hPGCLCs distributed at the outermost
surface monolayer of EBs (POU5F1 protein is stained brown with hematoxylin counterstaining). (Right) hPGCLCs are found as aggregates at EB surface (no
counterstaining). Arrows indicate aggregated cells strongly expressing POU5F1. (C) Statistical evaluation of surface enrichment of POU5F1++ (strongly pos-
itive) hPGCLCs. (Left) Definition of the “surface layer,” which is the outermost surface monolayer of EBs, and the “internal area,” which is the remaining
region. (Center) Number of POU5F1++ cells in the internal or surface regions of each EB (n = 23; P value was calculated by paired t test). (Right) Box plot
representation of percentage localization of POU5F1++ cells in the internal or surface regions of EBs. (D) Time-lapse live imaging of a CD38+ hPGCLC showing
active cell migration. A live EB was immobilized on Matrigel overnight, and an hPGCLC that emerged from the EB mass was stained with a fluorescence dye-
conjugated anti-CD38 antibody. Fluorescence images were taken before and after a 60-min time lapse and digitally converted to green and orange pseu-
docolors, respectively. The CD38+ hPGCLC marked as a showed a well-developed cellular protrusion (arrowheads) and moved to the location marked as b
within 60 min. (E) Expression of the CXCR4 chemotaxis receptor and its ligand CXCL12 in human germline cells and gonadal somatic cells. RNA-seq data
generated in four independent laboratories were conormalized to obtain relative expression profiles (of CXCR4 and CXCL12 mRNA across cell types. cpm,
Counts per million. (F) FACS analysis of total day 5 EB cells for cell surface expression of CD38 and CXCR4. The double-stained FACS chart indicates gates for
single- and double-positive cells.
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strategies (Fig. 3). Based on the transcriptomal profiling along
with steps of hPGCLC production (Fig. 2 A and B), we speculate
that specific induction of cluster 2 genes may be important for
germline differentiation of EB cells, while persistent expression
of cluster 3 genes may prevent differentiation to somatic line-
ages. Irie et al. (15) reported that human ES cells (hESCs)
maintained in the 4i medium for more than 2 wk showed a slight
up-regulation of T and HAND1 compared with the conventional
hESCs, speculating that 4i-reprogrammed hESCs might have
primitive streak-like features, which could explain the compe-
tence to directly give rise to hPGCLCs. Our data also show a
slight but significant increase in expression of T in the short-term
4i reprogrammed hiPSCs compared with the primed-state
hiPSCs (Fig. 2B). Future studies will be needed to evaluate the
relevance of the short-term 4i reprogrammed cells with the
primitive streak-like state. KJF4, TFAP2C, and cluster 1 genes,
with importance in specification of hPGC/hPGCLCs that has
been shown or predicted, were expressed in both CD38+ and
CD38− EB cells. Expression of KLF4, TCL1B, and TFCP2L1,
which are markers of ICM-like strong naïve pluripotency (16,
20), may imply a certain degree of commonality of gene networks
between EB cells exposed to the hPGCLC medium and ICMs.
The strong expression of hPGC/hPGCLC markers, such as
NANOS3 (15), indicates that our CD38+ cells isolated from day 5
EBs are hPGCLCs. However, weak but significant expression of
NANOS3 and SOX17 in CD38− EB cells at day 5 (Fig. 2B) might
reflect their undergoing commitment to germline differentiation.
Kobayashi et al. (18) recently showed that high levels of SOX17
are needed for robust induction of hPGCLCs. While SOX17 is
essential for hPGCLC induction (15), it is not a specific germline
maker but also labels mesendodermal cells. Additional studies
will be necessary to determine whether the predicted hPGCLC
precursor cells weakly expressing SOX17 and/or NANOS3 in the
CD38− cells in day 5 EBs can later differentiate to hPGCLCs.
We also observed that the PRDM1 mRNA transcripts expressed
in CD38− EB cells lacked the 3′-UTR harboring miRNA binding
sites required for regulation of mRNA stability (26–28) (Fig. 2D
and Fig. S2). Whether the 3′-UTR polymorphism of PRDM1
mRNA and/or let-7 miRNA have significance in hiPSC differ-
entiation to hPGCLCs remains to be determined.
Specification of mouse PGCs requires coordinated actions of
three TFs—namely Prdm1, Prdm14, and Tfap2C—which have
been described as a tripartite TF network (5, 13, 14). In contrast,
specification of hPGCLCs is dependent on SOX17, which induces
PRDM1 (15) and endoderm genes. PRDM1 plays critical roles in
specification of hPGCs/hPGCLCs by suppressing SOX17-induced
expression of endodermal genes as well as BMP- or WNT-induced
expression of mesodermal genes (13, 18). Whereas TFAP2C
mRNA was strongly expressed in both CD38+ hPGCLCs and
CD38− EB cells (Figs. 2 A and B and 3 and Figs. S1, S3, and S4),
promoter sequences of DEGs up-regulated in hPGCLCs were
significantly enriched with the TFAP2 binding motif (Fig. 4A).
Fig. 6. Effects of CXCL12 on mRNA expression in hPGCLCs. (A) Expression of mRNA transcripts in CD38+ hPGCLCs or CD38− EB cells at day 8 EBs. EBs were
cultured in the standard condition until day 5 and then incubated for an additional 3 d in the presence or absence of Rho Kinase Inhibitor (ROCKi) and/or
CXCL12 in the PGCLC production medium. Amounts of mRNA expression are shown as counts per million (cpm) values of normalized reads of three repeated
RNA-seq experiments. (B and C) GO analysis of DEGs in hPGCLCs produced in the ROCKi-deficient medium in the presence or absence of CXCL12. Three RNA-
seq experiments determined 1,190 up-regulated (B) and 735 down-regulated (C) DEGs. Statistically significant GO terms (FDR < 5%) are shown. (D) RNA-seq
traces of CXCR4, PTGER3, BCL2, and CASP8 mRNA expression. The height of peaks represents relative mRNA expression of a gene in the six cell culture
conditions and was normalized for each gene. ZRAMB2 locates adjacent to PTGER3 and is shown as control. KDSR and VPS4B are controls located adjacent to
BCL2. ACTB expression shows quantitative reproducible RNA-seq experiments across the six different cell culture conditions. Note that PTGER3 and
BCL2 traces are shown only at representative exons.
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Interestingly, these possible TFAP2-regulated DEGs up-regulated
in hPGCLCs (Table S2) included SOX17, NANOS3, and T (Fig.
4B). These results support the importance of TFAP2C in hiPSC
differentiation to hPGCLCs, although its expression is not re-
stricted to hPGCLCs.
GO analysis of DEGs up-regulated in CD38+ hPGCLCs
compared with CD38− EB cells revealed significant enrichment
of genes involved in cellular activities relevant to migration, in-
cluding cell projection morphogenesis, or regulation of loco-
motion (Fig. 2E). Promoter sequences of these DEGs were
significantly enriched with the binding motif of RREB-1 (Fig.
4A), a TF required for migration and spreading of human MCF-
10A cells (34). Defects of its Drosophila homolog gene hindsignt
caused excess accumulation of intercellular adhesion molecules
and suppression of cell spreading in ovarian follicular epithe-
lium, indicating its importance in reducing cell–cell adhesion
when interconnected groups of cells undergo dynamic changes in
cell shape (34). Based on these roles of hindgut/RREB-1, we
speculate that human RREB-1 may be important during mi-
gration of PGCs, involving transient and reversible adhesion of
PGCs to other types of cells as well as to marked changes in cell
shape (Fig. 5D).
We detected hPGCLCs in EBs almost exclusively at their
outermost surface monolayer (Fig. 5 A and C and Fig. S7 A and
B). Live cell imaging revealed active migration of hPGCLCs
(Fig. 5D). In mouse EBs it has been shown that only the out-
ermost surface monolayer will differentiate to primitive endo-
derm (PrE) and noteworthy visceral endoderm (VE) (39, 40).
This is because in vivo specification of mouse PGCs from epi-
blast requires BMP2 secreted from VE to activate the tripartite
TF network (5). Before implantation, mouse PrE deposits
basement membrane (BM) to its boundary with ICM, and this
BM is apparently required for PrE differentiation to VE (40).
Similarly, several BM proteins are deposited beneath the out-
ermost monolayer of mouse EBs (41, 42). Mouse PSCs partially
differentiated toward PrE emerge in the standard naïve pluri-
potency culture, and on EB formation, such PrE-primed PSCs
move toward the outside because of differential adhesion (39,
40). Exclusive localization of hPGCLCs at the outermost
monolayer of EBs might occur for similar reasons. The distri-
bution of hPGCLCs in wide areas of EB surface without ag-
gregation may reflect their random migration on the subsurface
BM. Compared with the conventional methods for forming loose
cell aggregates using low-attachment U- or V-shaped wells
(Table S1), our use of microwells for the spin method EB for-
mation (19) may increase initial density of hiPSCs, resulting in
tighter intercellular adhesion, which in turn, affects directed
differentiation of EBs (40).
Our GO analysis of DEGs between CD38+ hPGCLCs and
CD38− EB cells in day 5 EBs revealed significant enrichment of
cell migration genes (Fig. 2E). CXCR4 was strongly expressed in
all hPGCLCs (Figs. 5 E and F and 6A), whereas expression of
CXCL12 in whole EB cells was weak (Fig. 5E). Expression of
c-KIT, another plasma membrane receptor involved in PGC mi-
gration and survival, was also strong in CD38+ hPGCLCs (Fig. 2 A
and B and Figs. S3 D and E and S4 F and G). Importantly, our
hPGCLC production medium contained stem cell factor (SCF),
the c-KIT ligand, which is also the case for most other hPGCLC
production protocols (Table S1). Removal of SCF from the
hPGCLC production medium resulted in significant dismantling
of EBs with no yield of hPGCLCs. In mouse embryos, CXCL12 is
produced at the genital ridges and diffused into the surrounding
mesenchyme, guiding chemotactic migration of CXCR4+ PGCs
(36, 43) (Fig. S8). In contrast, SCF is expressed by somatic cells
throughout the path of PGC migration to support survival and the
random migratory activities of PGCs (43–45) (Fig. S8). Supported
by SCF in the medium, hPGCLCs may survive and randomly
migrate on the surface of EBs. We, therefore, speculate that
hPGCLCs at the surface of EBs may resemble the prechemotactic
embryonic hPGCs in the midline regions (Fig. S8). The reported
low degree of gDNA demethylation in hPGCLCs agrees with the
notion that hPGCLCs resemble midline hPGCs (9, 15–17, 20).
Exposure of hPGCLCs at the surface of EBs to CXCL12 in
the absence of ROCK1/2 inhibitor induced cell migration genes
and antiapoptotic genes (Fig. 6 A and B), while expression of
CASP8 was suppressed (Fig. 6A). These results may imply that
the midline hPGCs may be prone to the extrinsic pathway apo-
ptosis until the exposure to CXCL12 (Fig. S8). Exposure of
hPGCLCs to CSCL12 also induced PTGER3 (Fig. 6A). Notably,
Ptger3 activation has been reported to be required for expression
of both Cxcr4 and Cxcl12 by dendritic cells in mouse lymph
nodes (46), and a nine-gene biomarker predicting metastatic
prognosis of human head and neck squamous cell carcinomas
with 90% accuracy included CXCR4, CXCL12, and PTGER3
(47). It is thus interesting to speculate that there may be func-
tional interactions between prostaglandin E2 signaling and
CXCL12 signaling in hPGCs/hPGCLCs.
In summary, we have shown robust production of hPGCLCs
after a 72-h culture of primed pluripotency hiPSCs in the 4i
medium as well as transcriptomal consistency of hPGCLCs using
different protocols and/or FACS enrichment antigens. Most
hPGCLCs strongly expressed CXCR4 and were localized at the
outermost surface monolayer of EBs. Exposure of hPGCLCs to
CXCL12 induced migratory and antiapoptotic genes. Thus, our
results provide evidence that hPGCLCs produced using different
protocols have comparable biological characteristics resembling
prechemotactic, embryonic midline hPGCs.
Materials and Methods
Footprint-free hiPSC clones were generated from commercially available,
deidentified neonatal foreskin dermal fibroblasts and maintained in
mTeSR1 on Matrigel. hPGCLCs were generated from hiPSCs using a protocol
based on the study of Irie et al. (15), with modifications involving 72-h ex-
posure of primed pluripotency hiPSCs to the 4i medium and the use of
AggreWell microwells for the spin EB technique of EB formation (19). CD38+
and CD38− cells were FACS-enriched from single-cell suspension using FACS.
Total RNA was subjected to TaqMan qPCR or RNA-seq using Illumina Next-
Seq 500, and deep sequencing data were analyzed using the STAR aligner
and R/Bioconductor packages Rsubread, edgeR, prcomp, and plot3D. Pro-
moter enrichment analysis of TF binding motifs was performed using the
TRANSFAC database. Immunohistochemistry of FFPE serial sections was
performed using standard methods. Time-lapse immunofluorescence live
imaging was performed on EBs spread on Matrigel using fluorescence dye-
conjugated anti-CD38 antibodies and an inverted fluorescence microscope.
Detailed methods are provided in SI Methods.
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